We developed transgenic (Tg) rats that express human CD4, CCR5, CXCR4, CyclinT1, and CRM1 genes. Tg rat macrophages were efficiently infected with HIV-1 and supported production of infectious progeny virus. By contrast, both rat primary CD4 + T cells and established T cell lines expressing human CD4, CCR5, CyclinT1, and CRM1 genes were infected inefficiently, but this was ameliorated by inhibition of cyclophilin A. The infectivity of rat T cellderived virus was lower than that of human T cell-derived virus.
Introduction
A convenient HIV-1-susceptible small animal model with an intact immune system is desirable for accelerating development of prophylactic vaccines and novel antiviral therapies. The ability to infect rodents with HIV-1 would make them a useful model because they are established experimental animals, inbred strains are available, and they can be readily genetically manipulated. However, a fully permissive model has not yet been established because of several inherent obstacles to HIV-1 replication in rodent cells. One major barrier occurs at the level of viral entry into the cell, which may be overcome by introducing human CD4 (hCD4) and CCR5 (hCCR5) (Keppler et al. 2001 (Keppler et al. , 2002 . Indeed, transgenic (Tg) rats, albeit the outbred Sprague Dawley (SD) strain, expressing these receptors support HIV-1 infection to some extent, and have been used to evaluate antiretroviral compounds (Goffinet et al. 2007a, b) . Mice expressing hCD4 and hCCR5 along with human CyclinT1 (hCycT1) are also susceptible to infection with HIV-1 (as detected using a highly sensitive method such as the HIV-1-harboring luciferase gene system) (Seay et al. 2013) . However, in these studies, the rodents were injected with a very large amount of HIV-1 and systemic viremia was never detected.
Studies of rodent cells also indicate the existence of postentry blocks at both early and late phases of the HIV-1 replication cycle (Bieniasz & Cullen 2000; Mariani et al. 2000) . Blockade at the stages of nuclear import and integration of viral genomic DNA has been reported in mouse cells (Tsurutani et al. 2007; Tervo et al. 2008) . However, rat cells support all early steps, including integration, suggesting that the rat is a more promising rodent model (Goffinet et al. 2007a,b) . However, another study shows that rat T cells have a lower efficiency of infection than human T cells, particularly when a small amount of virus, mimicking natural infection, was administered (Baumann et al. 2004) . Thus, further studies are needed to establish the efficiency of the early stage of HIV-1 infection in rat cells.
It is well established that hCycT1, a cofactor for the HIV tat protein, is required to support HIV-1 transcription in mouse cells (Bieniasz et al. 1998; Garber et al. 1998; Sun et al. 2006) . Furthermore, triple Tg mice expressing hCD4, hCCR5, and hCycT1 are much more susceptible to infection than double Tg mice lacking hCycT1 (Seay et al. 2013) . By contrast, some rat cell lines support HIV-1 transcription without hCycT1 (Keppler et al. 2001) , and triple Tg SD rats show a variable effect of hCycT1 expression, which may be ascribed to the individuality of outbred rats (Michel et al. 2009) .
During the late phase including formation and release of infectious progeny virus, less efficient synthesis of gag and envelope (env) proteins occurs in both mouse and rat cells. This can be overcome by supplementation with the human CRM1 gene (hCRM1), a cellular cofactor for the rev protein that transports gag/env mRNAs and genomic RNA from the nucleus to the cytoplasm (Okada et al. 2009; Nagai-Fukataki et al. 2011; Sherer et al. 2011) . Inefficient release of virions in rodent cells is ascribed to rodent Bst2 (also called tetherin or CD317), an antiviral response protein that is resistant to HIV Vpu-mediated degradation (Goffinet et al. , 2010 . It is in contrast to human Bst2 that is degraded by Vpu (Neil et al. 2008) . Moreover, mouse mRNA editing enzyme Apobec 3 impairs infectivity of progeny viruses and, in contrast to the human Apobec 3 family (Sheehy et al. 2002) , is resistant to Vif proteinmediated degradation (Mariani et al. 2003) . On the other hand, the function of rat Apobec 3 remains elusive.
Previously, we constructed double Tg rats that express both hCRM1 and hCycT1 but lack hCD4 and hCCR5. In these rats, expression of hCycT1 profoundly enhanced production of virus when HIV-1 genome was introduced by electroporation or VSV G protein-coated virus was infected to CD4 + T cells, while this was less efficient in macrophages. Conversely, expression of hCRM1 profoundly increased production of virus in macrophages, but less efficiently in CD4 + T cells. Thus, expression of both hCycT1 and hCRM1 markedly augments HIV-1 production in both CD4 + T cells and macrophages (Okada et al. 2009 ).
Here, we report the construction of Tg rats that express hCycT1 and hCRM1 in addition to a complex of human receptors (including hCD4, hCCR5, and human CXCR4 (hCXCR4)). We examined the susceptibility of these rat Tg cells to HIV-1 infection and found that Tg rat-derived macrophages support HIV-1 infection moderately well. By contrast, Tg rat primary CD4
+ T cells and a T cell line expressing hCD4, hCCR5, hCycT1, and hCRM1 both are inefficiently infected with HIV-1; this can be overcome by inhibiting the function of cyclophilin A (CypA).
Results

Characterization of the Tg rats
In this study, we constructed three lines of Tg rat expressing either hCCR5 or hCXCR4, or doubly expressing hCD4/hCycT1 (designated F4Y). These lines were then mated together and with the hCRM1 Tg rat constructed previously (Takayanagi et al. 2007) to develop progeny (designated F54YXM) that express all five human antigens: hCD4, hCCR5, hCXCR4, hCycT1, and hCRM1.
First, T cells expressing rat CD4 + T cells and alveolar macrophages were prepared from the F54YXM rats and expression of hCD4 and hCCR5 was examined by flow cytometry. As shown in Fig. 1a , almost all rat CD4 + T cells isolated from spleen expressed both hCD4 and hCCR5, whereas hCXCR4 expression was variable on hCD4 + splenocytes. A substantial proportion of alveolar macrophages expressed both hCD4 and hCCR5. Next, we examined expression of hCRM1 and hCycT1 in rat CD4 + splenic T cells by Western blotting. Both hCycT1 and hCRM1 were expressed in activated F54YXM CD4 + T cells (Fig. 1b) , but the level of hCycT1 expression was somewhat lower than that in CD4 + T cells from hCRM1/hCycT1 double Tg rats reported previously (Okada et al. 2009 ). This could be ascribed to the usage in this study of an hCD4/hCycT1 double Tg rat (F4Y) as a parent instead of the hCycT1 single Tg rat used previously (Okada et al. 2009 ). Alternatively, the state of the primary T cells activated in vitro with the anti-CD3 and anti-CD28 antibodies (Abs) may vary between individual experiments. As the hCycT1 transgene is expressed in rat thymocytes without in vitro activation, we compared expression of hCycT1 in thymocytes prepared from the hCycT1 Tg with that in thymocytes from the F4Y Tg rats. As shown in Fig. 1c , F4Y Tg rat thymocytes expressed less hCycT1 than those from the hCycT1 Tg rat.
To assess the functionality of hCycT1 expressed in F4Y rat cells, we prepared splenocytes, activated with anti CD3/CD28 Abs, and then electroporated with pCRRE expressing gag p24 protein in an hCycT1-dependent manner (Nagai-Fukataki et al. 2011) . Measurement of p24 in the supernatant 2 days later showed that similar levels were synthesized in splenocytes from hCycT1 and F4Y Tg rats, which was 50 times more than that synthesized in wild-type rat cells. Moreover, F54YXM CD4 + T cells produced 37 times more p24 than wild-type cells, which was 1/10th the level of that of human CD4 + T cells (Table 1 ). The level of p24 produced in F54YXM CD4 + T cells was similar to that in CD4 + T cells from the hCRM1/hCycT1 double Tg rat described previously (Okada et al. 2009 ). Therefore, these results provide evidence that hCycT1 functions in the F54YXM rat as well as in the hCRM1/hCycT1 double Tg, albeit with a lower level of expression. 
Actin
Infectivity of HIV-1 in macrophages prepared from Tg rats
The efficiency of infection of alveolar macrophages derived from F54YXM Tg rats by HIV-1 was examined using the HIV-1 R5 strain AD8-E harboring the GFP gene just upstream of the nef gene (Terahara et al. 2012) , followed by flow cytometry analysis 3 days after infection. Figure 2a shows that hCCR5 + /hCD4 + macrophages allowed more efficient HIV-1 infection than human monocyte-derived macrophages (MDM). By contrast and as expected, hCD4
À /hCCR5 À /hCRM1 + rat macrophages were not susceptible to HIV-1 infection.
Next, we examined production of HIV-1 in F54YXM macrophages in a p24 ELISA after infection with the AD8-D variant harboring the DsRed gene just upstream of the nef gene (Yamamoto et al. 2009 ). Figure 2b shows that approximately 3 ng/mL p24 was produced from F54YXM macrophages at 9 and 14 days after infection, whereas the level of p24 was undetectable in a subset of hCCR5 À F4YRXM macrophages, showing that infection was hCD4/ hCCR5 dependent. The amount of p24 produced by F54YXM macrophages was similar to that produced by macrophages prepared from the hCRM1/hCycT1 double Tg rats infected with G-coated HIV-1 previously described (Okada et al. 2009 ).
To examine whether the progeny virus produced by the F54YXM macrophages can subsequently re-infect macrophages in the same culture, the reverse transcriptase inhibitor PMPA (also called Tenofovir as a commercial name; Balzarini et al. 1993; Che-Chung et al., 1995) was added 1 day after infection to prevent secondary infection, and the level of p24 production in the presence/absence of PMPA compared. As the half volume of culture medium was removed for quantification of p24 and then replenished with the same volume of fresh medium every 3 days, p24 levels decreased in the both cultures. After the peak at 3 days postinfection, the p24 level in the culture with PMPA dropped from its peak and remained low, indicating that secondary infection was prevented. By contrast, the p24 level in the culture without PMPA decreased after the peak at 3 days, but then rebounded, suggesting that secondary infection by the progeny virus had occurred (Fig. 2c) . Taken together, these results indicate that macrophages from F54YXM Tg rats are susceptible to HIV-1 infection and can support production of infectious progeny virus.
Infectivity of HIV-1 in rat T cells
In contrast to macrophages, we found that, compared with human CD4 + T cells, F54YXM CD4 + T cells were inefficiently infected by HIV-1, despite repeated testing (Fig. 3) . To examine the possibility of the presence of a postentry inhibitor, such as simian Trim5a (Stremlau et al. 2004 ), human and rat T cells were infected with VSV G protein-coated HIV-1 pseudotype virus. While the pseudotype virus infected human T cells in a dosedependent manner, it inefficiently infected rat T cells at the any doses tested, suggesting the presence of a postentry inhibitor (Fig. 4) . To examine HIV-1 infection of rat T cells in more detail, we constructed a rat CD4 + T cell line, FPM1h45T1, expressing hCD4, hCCR5, hCycT1, and hCRM1, and then tested the effect of cyclosporin A (CSA), which increases HIV-1 infection of simian cells (Towers et al. 2003) . As shown in Fig. 5a , HIV-1 AD8-E rarely infected FPM1h45T1 cells, despite their expression of hCD4 and hCCR5. Addition of CSA to the medium increased infection by approximately 10-fold, bringing it to 1/10th level of infection observed for the human CD4 + T cell line Molt4CCR5. Next, using short hairpin RNA (shRNA) in a PRIME lentivector system (Stegmeier et al. 2005) , we knocked down the CypA gene, a target of CSA, in FPM1h45T1 cells; this reduced the CypA expression level by approximately 2/3 (Fig. 5b) . The efficiency of infection to the knocked down cells (FPM1h45TshCA) was similar to that to FPM1h45T1 cells in the presence of 5 lM CSA. Next, to examine HIV-1 infection to primary F54YXM rat CD4 + T cells, we assessed the effect of CSA and of NIM811, a CSA derivative that prevents the association of CypA with HIV-1 Gag protein, but is not immunosuppressive (Billich et al. 1995) . CSA again enhanced HIV-1 infection, and NIM811 augmented infection even further, by up to half the rate of HIV-1 infection of human primary CD4 + T cells (Fig. 3 ). This may be because NM811 lacks immunosuppressive activity.
Next, we assessed AD8-E production by p24 ELISA in FPM1h45T1 cells in the presence or absence of CSA (Fig. 6 ). In the absence of CSA, FPM1h45T1 cells did not produce a significant amount of p24, most likely because of the very poor rate of infection. However, in the presence of CSA, FPM1h45T1 produced an average of 365 pg of p24. FPM1h45T1shCA cells produced similar amounts of p24 (510-660 pg) irrespective of the presence of CSA, which is coincident with the fact that knocking down CypA enables AD8-E to infect. Nevertheless, the amount of p24 produced in the rat T cells was a 1/150-300th of that produced in human Molt4CCR5 cells (average, 103 ng). We were unable to obtain reproducible results when examining the production of progeny viruses in primary CD4 + T ) prepared from F54YXM (black circles) or F5YXM (F54YXM lacking hCD4; black squares) Tg rats were infected with 100 ng AD8-E. The amount of p24 in the medium was then measured using p24 ELISA. The figure shows a representative result of two independent experiments. (c) One day after infection with 75 ng AD8-D, F54YXM macrophages were thoroughly washed with medium, followed by addition of 1 mL medium without (black squares) or with (black circles) PMPA at a final concentration of 20 lM. Half volume of the supernatant was taken for p24 quantification every 3 days and an equal volume of fresh medium was replenished. The figure shows a representative result of two independent experiments. MDM, monocyte-derived macrophages.
Genes to Cells (2017) 22, 424-435 cells derived from the Tg rats, probably because they were not stable in long-term culture. We therefore need to optimize the culture conditions for primary T cells that might be impaired by the expression of multiple human genes.
Infectivity of progeny viruses produced in rat T cells and macrophages was assessed using cell lines and primary cells (Fig. 7) . First, G-coated AD8-E was used as inoculum virus in the experiment 1 of Fig. 7a , because human CD4 + T cell line Jurkat and rat macrophage line NR8383, which does not express hCD4 nor hCCR5 (Okada et al. 2009 ), were employed as controls; 50 ng G-coated AD8-E could infect FPM1h45T1 cells to some extent even in the absence of CSA. In the experiment 2, a larger amount (100 ng) of AD8-E was infected in the presence of CSA to obtain a sufficient amount of the progeny, and human T cell lines Molt4CCR5 was used as a control. Three days after infection, the supernatant was subjected to p24 ELISA and an assay of infectivity, which relies on TZM-bl cells that produce b-galactosidase upon HIV-1 infection (Derdeyn et al. 2000) . b-galactosidase activity versus amount of p24 was used as a surrogate marker of relative infectivity. The progeny virus produced in FPM1h45T1 cells was less infectious than that produced in the human T cells, while the viruses produced in NR8383 cells exhibited infectivity comparable to those from Jurkat cells. To confirm the above results, we repeated the experiment 2, in which less amount (6 ng) of AD8-E was infected and the progeny viruses were harvested 4 days, instead of 3 days, postinfection. Again, the progeny virus produced in FPM1h45T1 cells was shown to be less infectious (Fig. 7b) . The infectivity of the HIV-1 produced in human monocyte-derived macrophage (hMDM) and rat primary macrophages derived from a hCRM1/ hCycT1Tg rat were assessed using G-coated NL43. The infectivities of the viruses produced in both cells were similar although they gradually decreased along with days after infection (Fig. 7c) . Taken together, rat T cell-borne viruses were less infectious while rat macrophage-derived viruses were as infectious as hMDM-derived viruses. + T cells prepared from F54YXM rat splenocytes and human PBMC were activated with anti-CD3 and anti-CD28 Abs and infected with 8 ng p24 CA equivalents of AD8-E in the presence or absence of 5 lM CSA and 4 lM NIM811. Two days later, the cells were fixed and analyzed for GFP expression by flow cytometry. The values obtained in two independent experiments were plotted, and their averages were calculated. 
Discussion
We investigated HIV-1 susceptibility in an inbred F344 rat Tg line, F54YXM, which co-expresses human hCD4, hCCR5, hCXCR4, hCycT1, and hCRM1. This Tg rat has been expected to be superior to the reported hCD4, hCCR5, and hCycT1 expressing triple Tg rats and mice in more efficient production of progeny viruses, because inefficient accessibility of Rev with rat CRM1 has been shown to be one of the major obstacles in propagation in rat cells (Okada et al. 2009; Nagai-Fukataki et al. 2011) . Actually, HIV-1 infection to macrophages prepared from the quintuple rats was as efficient as infection to human macrophages, and the Tg macrophages supported propagation as well as the hCycT1/hCRM1 Tg rat macrophages that supported better propagation of VSV G protein-coated HIV-1 than hcycT1 Tg rat macrophages (Okada et al. 2009 ). Multicycle infection to F54YXM rat macrophages was consistent with that previously reported (Keppler et al. 2002) , and with the fact that the rat primary and lined macrophageproduced HIV-1s are as infectious as that from the human macrophage and T cells. Therefore, the data suggest that our quintuple rats may have advantage in HIV-1 propagation in macrophages compared with hCD4/hCCR5/hCycT1 triple rats and mice.
However, we found that infection to rat CD4 + T cells was inefficient despite efficient expression of hCD4 and hCCR5, which is consistent with a report that examined CD58(NT)D, a rat T cell line (Baumann et al. 2004 ) and our own results using FPM1, another rat T cell line. However, this finding is contrary to a report describing efficient infection of hCD4/hCCR5-expressing CD4 + T cells from the outbred SD strain (Goffinet et al. 2007a,b) . This inconsistency could be ascribed to the difference in rat strains and/or the different in vitro activation methods (anti-CD3/CD28 Abs vs. IL-2/concanavalin A) used. In any case, the inefficient infection to rat CD4 + T cells may account for the undetectable systemic viremia in our hCD4/hCCR5/hCXCR4/ hCycT1/hCRM1-Tg rats (data not shown).
Inefficient infection of rat CD4 + T cells in the present study was partially rescued by inhibiting the function of CypA with CSA and NIM811, and by reducing the amount of CypA with shRNA. In contrast, our preliminary experiment suggested that CSA slightly reduced HIV-1 infection to rat macrophages (data not shown). Thus, these suggest that knocking out the CypA gene with the CRISPR/Cas9 system would facilitate construction of a rat infection model. This finding is reminiscent of simian cells restricting HIV-1 infection in a CypA-dependent manner (Towers et al. 2003) . Moreover, mutant HIV-1s that harbor G89V and V86P/H87Q/I91N/M96I mutations in the CypA binding domain of the capsid protein (Chatterji et al. 2005 ) infect rat T cells as inefficiently as wild-type HIV-1 (data not shown), suggesting that rat T cells are akin to a type of Old World monkey cell, but not to cells of the New , and Molt4CCR5 cells were infected with 3 ng p24 CA equivalents of AD8-E in the presence or absence of CSA. Two days later, the cells were fixed and analyzed for GFP expression by flow cytometry. The values obtained in a couple of independent experiments were plotted, and their averages were calculated. (b) Western blotting profile of the rat T cell line FPM1h45T1 and FPM1h45T1shCA, in which CypA mRNA was knocked down using the PRIME lentivirus vector system. Actin was used as a loading control.
Genes to Cells (2017) 22, 424-435 World owl monkey, which contain TRIM-Cyp, a fusion protein of Trim5a and CypA (Sayah et al. 2004) . These results implicate that rat T cells may harbor a Trim5a-like inhibitor.
After CypA was inhibited by drugs or shRNA, the rat CD4 + T cell line FPM1h45T1 produced HIV-1 at a level 1/150-1/300th that of the human CD4 + T cell line Molt4CCR5. Considering that its efficiency of infection was approximately 1/10th that of Molt4CCR5, a FPM1h45T1 cell is estimated to produce 1/15-1/30th as many progeny viruses as a Molt4CCR5 cell. Rat Bst2 may be a cause of the lower level of production, as it inhibits release of HIV-1 (Goffinet et al. 2010) .
Rat T cells produced progeny viruses with lower infectivity than human T cells, which is inconsistent with our previous report showing that electroporated full-sized R5 HIV-1 genomes produce fully infectious progeny viruses in rat T cells (Okada et al. 2009 ). We hypothesize that introduction of larger amounts of HIV-1 genomes by electroporation overcomes the putative inhibitor in the rat T cells. As mouse Apobec 3 has been reported to reduce HIV-1 infectivity (Mariani et al. 2003) , it may be worth testing the effect of rat Apobec 3.
In summary, to overcome the obstacle(s) in the late phase of HIV-1 infection cycle shown in hCD4/ hCCR5/hCycT1 triple Tg rat, we constructed the hCD4/hCCR5/hCXCR4/hCycT1/hCRM1 Tg rat based on the inbred F344 strain, and showed that the macrophages are susceptible to infection with HIV-1 and should produce more amounts of infectious progeny viruses than the triple Tg rat, while the CD4 + T cells are still refractory against HIV-1 infection. Our own and others' results suggest that knocking out the inhibitory genes such as CypA, Apobec 3, and Bst2 may facilitate construction of the better rat model for HIV-1 infection. Now, it is possible using CRISPR/ Cas9 system.
Experimental procedures
Construction of F344 Tg rats that express human genes
Rats were housed and maintained according to the Regulation on Animal Experimentation Guidelines at Hokkaido University. All experiments with rats were approved by the Committee for Experimental Use of Animals in the Hokkaido University.
The hCRM1 Tg rat was described previously (Takayanagi et al. 2007) . Double Tg rats expressing hCD4 and hCycT1 were developed by simultaneous microinjection of a plasmid (which harbors hCD4 cDNA driven by CD4 regulatory sequences including the murine CD4 enhancer, hCD4 intron 1, and hCD4 promoter) (Killeen et al. 1993) into fertilized F344 rat eggs and a BAC clone that harbors genomic hCycT1 (Okada et al. 2009 ). Tg rats expressing hCXCR4 were developed by injection of the NCBI BAC clone, RP11-1140A6, which harbors the entire genomic hCXCR4 sequence, including the promoter. To develop the hCCR5 Tg rat, a plasmid containing hCCR5 cDNA under the control of the CD4 regulatory sequence was constructed and then injected into rat eggs. The four Tg rats described above were mated to create rats co-expressing hCD4, hCCR5, hCXCR4, hCRM1, and hCycT1. To identify Tg rats, total genomic DNA was extracted from tail snips, and the human genes were examined by PCR under the following conditions: for hCD4, primers CCTAAGCTGATGCTGAGCTTGAAA and GTCCTTAC CCTTGATGTTGGATT annealing at 57°C, with 30-s elongation, for 40 cycles; for hCCR5, primers GCTCAGGTCCC TACTGG and GGGCTGCGATTTGCTTC annealing at 50°C, with 20-s elongation, for 40 cycles: for hCXCR4, primers AGCATGACGGACAAGT and AGTCGGGAATAGT Figure 6 Production of p24 in rat and human T cell lines. FPM1h45T1, FPM1h45T1shCA, and Molt4CCR5 cells (5 9 10 4 ) were infected with 3 ng p24 CA equivalents of AD8-E in the presence or absence of CSA. After overnight adsorption, the cells were washed three times with medium and cultured for 3 days. The supernatant was then subjected to p24 ELISA assay. To measure the background level of p24 that may represent residual inoculum virus after washing, virus was adsorbed in the presence of 5 lM maraviroc, which prevents interaction between the env protein and CCR5. The difference in the amount of p24 in the samples in the absence and presence of maraviroc was regarded as a measure of progeny virus newly produced. The amounts of p24 in the samples without or with maraviroc were shown by black circles or triangles, respectively. The values obtained in a couple of independent experiments were plotted, and their averages were calculated.
CAGC annealing at 50°C, with 30-s elongation, for 40 cycles; for hCRM1, primers TGAGGTCAGGAGTTCAGG AT and CTCTGCCTCCTGGGTTCAA annealing at 69°C, with 15-s elongation, for 40 cycles; for hCyclinT1, primers CCAGTATTGAATATGTACCCTAGGTTTGG and CAA CACTGGAAGTTCTGGATAGGCC annealing at 58°C, with 1-min elongation, for 40 cycles.
Cells
The rat T cell line FPM1 (Koya et al. 1999 ) that is infected with HTLV-1 was cultured in RPMI1640 medium containing 10% fetal calf serum (FCS) and 0.1 mM 2-mercaptoethanol. The rat macrophage line NR8383 was cultured in RPMI1640, 15% FCS, and 0.1 mM 2-mercaptoethanol. The human T cell lines Jurkat and Molt4CCR5 were cultured in were infected with 50 ng p24 CA equivalents of G-coated AD8-E. The supernatant was subjected to p24 ELISA and a TZM-bl cell assay 3 days after infection. The activity of b-galactosidase induced in TZM-bl cells upon HIV-1 infection was measured by a standard colorimetric method. The ratio of b-galactosidase activity/p24 was calculated. The relative infectivity of HIV-1 from human T cells was normalized to 100. (Exp. 2) Molt4CCR5 and FPM1h45T1 cells (1 9 10 5 ) were infected with 100 ng p24 CA equivalents of AD8-E in the absence or presence of 5 lM CSA, respectively. The medium was then subjected to p24 ELISA and a TZM-bl cell assay 3 days after infection. (b) Molt4CCR5 and FPM1h45T1 cells (1 9 10 5 ) were infected with 6 ng p24 CA equivalents of AD8-E in the absence or presence of 5 lM CSA, respectively. The medium was then subjected to p24 ELISA and a TZM-bl cell assay 4 days after infection. The duplicate values obtained in a representative one of two independent experiments were plotted. (c) 5 9 10 5 human monocyte-derived macrophages (hMDM) and hCRM1/hCycT1 rat-derived macrophages (rat M/) were infected with 50 ng p24 CA equivalent of G-coated NL43. The supernatant was subjected to p24 ELISA and a TZMbl cell assay 5, 7, and 9 days after infection. The activity of luciferase induced in TZM-bl cells upon HIV-1 infection was measured by luminometer. The ratio of luciferase activity/p24 was calculated. Averages and SD were calculated based on the triplicate values obtained in a representative one of two independent experiments.
Genes to Cells (2017) 22, 424-435 RPMI1640 containing 10% FCS without or with 100 lg/mL G418. The FPM1h45T1 cell line, which expresses hCRM1, hCD4, hCCR5, and hCycT1, was constructed as for the FPM1CRM1/CycT1 cell line (Okada et al. 2009 ) using an MX retrovector expressing hCCR5 cDNA (Onishi et al. 1996; Morita et al. 2000) and a lentivector expressing hCD4 cDNA (Miyoshi et al. 1998) , as described previously (Zhang et al. 2006) , and maintained in RPMI1640, 10% FCS, 0.1 mM 2-mercaptoethanol, 100 lg/mL G418, 1 lg/mL puromycin, and 20 lg/mL blasticidin S. The expression of hCD4 and hCCR5 was verified by flow cytometry using a FACSCalibur, a PE-conjugated anti-hCD4 Ab (eBioscience, San Diego, CA, USA), and a Cy5-conjugated anti-hCCR5 Ab (produced by Dr Yuetsu Tanaka). Expression of hCycT1 and hCRM1 was ascertained by Western blotting as described previously (Okada et al. 2009) . A CypA knocking down cell, FPM1h45T1shCA, was constructed using a PRIME lentivirus vector system, which includes the target sequence GTTCCTCCTTTCACA-GAA for rat CypA mRNA (Stegmeier et al. 2005) .
Rat primary CD4 + T cells were prepared and activated as described previously (Okada et al. 2009 ). Rat alveolar macrophages were prepared according to a standard procedure (Zhang et al. 2008) . Rat thymocytes were prepared by homogenizing rat thymus in PBS.
Human peripheral blood mononuclear cells (PBMCs) from healthy donors were isolated using Ficoll Paque Plus (Amersham Biotechnology) density centrifugation. Then, the CD4 + T cells were positively selected with anti-hCD4 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and expanded with Dynabeads human T-activator CD3/CD28 (Invitrogen, Carlsbad, CA, USA) in the presence of 30 U/mL interleukin (IL)-2 for 3 days. Human MDMs were prepared as described previously (Okada et al. 2009 ).
Electroporation
Ten million rat or human primary cells were electroporated with 4 lg pCRRE harboring HIV-1 gag gene (Nagai-Fukataki et al. 2011 ) and 1 lg pMax-GFP using Nucleofector II (Amaxa Biosystems, Gaithersburg, MD, USA). Mouse T cell Nucleofector kits was used under the electroporate conditions X-01 for the rat cells, while human T cell Nucleofector kits was used under U-14 for the human cells (Okada et al. 2009 ). Two days later, p24 in the supernatant was quantified by p24 ELISA.
Viruses
Infectious HIV-1 strains AD8-E and AD8-D were produced in 293T cells transfected with plasmids harboring the full genomes (Yamamoto et al. 2009; Terahara et al. 2012) . The amount of each was quantitated using a p24 ELISA kit (Zeptometrix) and their infectivity was determined using a TZMbl cell-based assay (Montefiori 2005) . VSV G-coated HIV-1 Lai3ΔenvGFP (Yamashita & Emerman 2004 ) was produced by transfecting 2.5 9 10 6 293T cells with 5 lg pLai3ΔenvGFP and 5 lg pVSV-G.
Infection
Cells (1 9 10 6 /mL) were infected with HIV-1 in the presence of 10 lg/mL polybrene at 37°C overnight, and then washed three times with medium. Fresh medium was added to adjust the cell density to 5 9 10 4 -1 9 10 5 cells/mL and cultured for several days as indicated in the figures. The amount and infectivity of the progeny viruses produced was quantitated by p24 ELISA and TZM-bl assay (Zhang et al. 2010) .
To assess the rate of infection, maraviroc, an inhibitor of the CCR5-HIV-1 env interaction (Roche et al. 2011) , was added at a final concentration of 5 lM after overnight infection to prevent multicycle infection. The next day, cells were fixed in PBS containing 2% paraformaldehyde and the percentage of GFP + cells was calculated based on flow cytometric analysis with a FACSCalibur cytometer.
Synthesis of NIM811
NIM811 was synthesized in house according to the procedure reported previously (Hubler et al. 2000) . The synthesized NIM811 was purified by reversed-phase HPLC using 45%-100% gradient MeCN in Milli-Q water with 0.1% TFA over 60 min, flow rate: 4 mL/min, UV: 214 nm and 254 nm, affording NIM811 as a white powder after lyophilization in >99% purity.
